Bicocca Open Archive

Logo unimib boa
LISSONI, ANDREA ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.812
EU - Europa 3.300
AS - Asia 1.323
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 9
AF - Africa 6
OC - Oceania 3
Totale 13.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.646
IT - Italia 593
CN - Cina 587
SE - Svezia 492
UA - Ucraina 479
IE - Irlanda 469
DE - Germania 379
SG - Singapore 356
RU - Federazione Russa 277
HK - Hong Kong 200
GB - Regno Unito 170
CA - Canada 165
FI - Finlandia 128
AT - Austria 108
VN - Vietnam 79
FR - Francia 68
DK - Danimarca 45
IN - India 34
NL - Olanda 34
TR - Turchia 22
BE - Belgio 19
JP - Giappone 12
EU - Europa 9
PL - Polonia 9
BR - Brasile 8
ES - Italia 8
IR - Iran 8
KR - Corea 7
ID - Indonesia 6
RO - Romania 5
TW - Taiwan 4
AU - Australia 3
CH - Svizzera 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IL - Israele 2
MA - Marocco 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
Totale 13.464
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.843
Woodbridge 1.187
Fairfield 676
Houston 663
Jacksonville 519
Dublin 437
Chandler 414
Wilmington 399
Ashburn 350
Dearborn 335
Singapore 298
Seattle 293
Frankfurt am Main 269
Cambridge 255
Princeton 218
New York 206
Hong Kong 189
Milan 148
Vienna 108
Altamura 106
Lawrence 104
Nanjing 104
Lachine 91
Shanghai 77
Beijing 74
Santa Clara 74
Fremont 49
Andover 46
Boardman 46
San Diego 43
Nanchang 37
Helsinki 35
Ottawa 35
Hebei 34
Guangzhou 28
Jiaxing 28
Toronto 28
Shenyang 27
Changsha 23
Huizen 22
London 21
Tianjin 21
Los Angeles 20
Falls Church 19
Brussels 18
Norwalk 18
Rome 18
Kunming 17
Lissone 17
Dallas 16
Detroit 15
Chicago 14
Dong Ket 14
Hangzhou 14
Pune 14
Mountain View 13
Jinan 9
Shenzhen 9
University Park 9
Auburn Hills 8
Florence 8
Redmond 8
Edmonton 7
Lanzhou 7
Leawood 7
Moscow 7
Munich 7
Jakarta 6
Kiev 6
Palermo 6
Sacramento 6
San Mateo 6
Zhengzhou 6
Fuzhou 5
Hefei 5
Hounslow 5
Kraków 5
Taizhou 5
Tappahannock 5
Torre Del Greco 5
Brescia 4
Changchun 4
Chiswick 4
Cinisello Balsamo 4
Miami 4
Ningbo 4
Padova 4
Prescot 4
Seregno 4
Taipei 4
Turin 4
Zanjan 4
Amsterdam 3
Carate Brianza 3
Castelleone 3
Central 3
Cormano 3
Desio 3
Garbagnate Milanese 3
Groningen 3
Totale 10.416
Salva come PNG Salva come JPEG
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 477
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 357
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 284
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 244
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential 243
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 224
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production 214
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial 202
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 201
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 195
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer 190
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 179
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 175
Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases 167
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 166
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 166
Uterine leiomyosarcoma: analysis of treatment failures and survival 164
Pre-operative morphological and colour Doppler features of borderline ovarian tumours 164
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 160
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 156
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 155
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale 154
Prospective multicenter study on the clinical utility of CA 72.4 in post-menopausal patients with pelvic mass 152
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 148
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 148
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells 147
Prospective multicenter study on CA 125 in postmenopausal pelvic masses 145
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale 144
Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study 144
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 141
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 140
Synchronous early-stage endometrial and ovarian cancer 138
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 137
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial 136
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy 134
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 133
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies 132
Endometrial stromal sarcoma: analysis of treatment failures and survival 132
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 132
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas 131
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 131
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 131
Safety of transvaginal fine needle puncture of gynecologic masses: a report after 500 consecutive procedures 130
Antiemetic efficacy of granisetron in patients with gynecological malignancies 127
Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients 126
Color Doppler ultrasound in the preoperative assessment of adnexal masses 125
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses 124
Optimal treatment of early-stage ovarian cancer 124
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 123
Ultrasound in the follow-up of young patients with malignant ovarian tumors after conservative surgery 122
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 122
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 121
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 120
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 120
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 119
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994 112
Endometriomas: Their ultrasound characteristics 111
Ultrasound characteristics of endometrial hyperplasia described using IETA terms 111
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer 110
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review 109
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 109
Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary 109
Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients 108
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 107
Clinically oriented three-step strategy to the assessment of adnexal pathology 107
Alpha-fetoprotein in the management of germ cell tumors of the ovary 106
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes 105
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 105
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells 104
Second-look laparotomy in the management of fallopian tube carcinoma 103
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma 103
Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study 102
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients 99
Brain metastases from endometrial carcinoma 99
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study 97
Ifosfamide in the treatment of malignant epithelial ovarian tumors 96
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study 95
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice 93
Tumor volume as risk factor for nodal diffusion in endometrial cancer 93
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis 91
Detection of abnormal intrauterine vascularization by color Doppler imaging: A possible additional aid for the follow up of patients with gestational trophoblastic tumors 90
Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can reliably classify them as benign or malignant before surgery? 89
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas 85
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 85
ΔNp63 expression is associated with poor survival in ovarian cancer 84
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 81
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial 79
Neoplasie dell’apparato genitale femminile 79
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer 77
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 75
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer 75
Fertility-sparing surgery in uterine leiomyosarcoma 74
Comparison of methods for monitoring young women with stage I borderline ovarian tumor after conservative surgery 73
Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases 73
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial 71
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females 71
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer 71
Total neuropathy scale items as early predictors of chemotherapy‐induced peripheral neurotoxicity 70
A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy 70
The risk of malignancy in unilocular cysts: a study on 1148 adnexal masses classified as unilocular cysts at transvaginal scan with review of the literature 67
Totale 13.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.265 0 0 218 246 268 335 369 191 286 119 187 46
2020/20211.887 124 82 178 186 122 153 192 179 195 208 109 159
2021/20221.185 74 91 81 112 105 94 55 91 56 85 108 233
2022/20231.892 256 577 134 137 182 297 13 90 125 17 31 33
2023/20241.380 38 43 77 73 181 353 264 33 133 39 19 127
2024/2025870 195 512 163 0 0 0 0 0 0 0 0 0
Totale 13.850